20
Participants
Start Date
October 4, 2024
Primary Completion Date
June 14, 2027
Study Completion Date
June 14, 2028
MRF with neurocognative studies
Magnetic Resonance Imaging is used to assess the risk of neurocognitive side effects in pediatric and AYA patients with acute leukemia receiving chemotherapy and participants will also be asked to complete a neurocognitive battery designed by Cogstate and administered on iPad in a simple gaming format
RECRUITING
University Hospitals Cleveland Medical Center, Rainbow Babies & Children's Hospital, Case Comprehensive Cancer Center, Cleveland
Case Comprehensive Cancer Center
OTHER